Increasingly, early adolescents who are transgender or gender diverse (TGD) are seeking gender‐affirming healthcare services. Pediatric healthcare providers supported by professional guidelines are treating many of these children with gonadotropin‐releasing hormone agonists (GnRHa), which reversibly block pubertal development, giving the child and their family more time in which to explore the possibility of medical transition.

中文翻译：

---

评论：跨性别和性别多元化青年的青春期阻滞剂——对文献的批判性评论

越来越多的跨性别或性别多元化 (TGD) 的早期青少年正在寻求性别肯定的医疗保健服务。在专业指南的支持下，儿科医疗保健提供者正在使用促性腺激素释放激素激动剂 (GnRHa) 治疗这些儿童，这种药物可逆地阻碍青春期发育，让孩子及其家人有更多时间探索医疗过渡的可能性。